Skip to content

Assessment for clinical curative effect of YangXinXue KeLi granule in the treatment of chronic heart failure

Assessment for clinical curative effect of YangXinXue KeLi granule in the treatment of chronic heart failure

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17010696
Enrollment
Unknown
Registered
2017-02-21
Start date
2017-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic heart failure

Interventions

Experimental group:YangXinXueKeLi

Sponsors

Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) in line with the diagnostic criteria of chronic heart failure, and symptoms > 3 months; (2) the patient group before in clinical stability (using a fixed dose of western medicine treatment is more than 2 weeks); First detected in chronic heart failure, or did not start treatment of patients; (3) the heart colour to exceed EF value < 40%; (4) NT - BNP acuity 450 pg/ml; (5) meet the diagnostic criteria of TCM of chronic heart failure; (6) Aged 50 to 80 years old; (7)All landowners signed informed consent.

Exclusion criteria

Exclusion criteria: (1) due to heart valve disease, congenital heart disease, pericardial disease, arrhythmia, or other non cardiac causes of chronic heart failure; (2) combination of uncontrolled sustained ventricular tachycardia, serious arrhythmia; (3) into the group 2 months before the occurrence of acute myocardial infarction, coronary angioplasty, coronary artery bypass surgery, patients with cerebrovascular accident; (4) not installed a pacemaker of sick sinus syndrome and 2 degrees, three patients with conduction block; (5) High blood pressure patients with failing to control, BP > 180 MMHG; (6) Those with liver and kidney and the endocrine system, hematopoietic system, severe primary disease; (7) All landowners pregnancy or lactation women; (8) Was allergic constitution and to a variety of drug allergy; (9) Pet-name ruby cannot cooperate to complete 6 minutes walking distance test patients; (10) Attending not signed informed consent.

Design outcomes

Primary

MeasureTime frame
Routine blood test;Electrocardiogram;BNP;

Countries

China

Contacts

Public ContactPeiyang Gao

Affiliated Hospital of Chengdu University of Traditional Chinese Medicine

gaopy930@126.com+86 18980025566

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026